Zach McMahon is the CEO and co-founder of LUCID. He led the company to its first Pharma partnership to develop a DTx for Alzheimer’s, drawing on his background as a strategy consultant in biotech and digital health at ZS Associates, where he assisted clients in bringing new products to market. As CEO, Zach led LUCID in securing institutional funding, as well as being named the NEXT AI Valedictorian and winning Wallifornia Music Tech’s Best Startup Award. Zach holds an MBA with honors from the University of Toronto and a BS in Management Info-Systems.